Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICASSO: Cilostazol and Probucol in Ischemic Stroke Patients with High Hemorrhage Risk
NCT01013532Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- Jun 2009
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial of cilostazol and probucol in ischemic stroke (4 arms), sponsored by Asan Medical Center. Primary endpoints: Time to the first occurrence of cerebral hemorrhage and Time to the first occurrence of composite cardiovascular events. Status: unknown.
02
Drugs
cilostazolprobucol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01013532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01013532.